Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Minority Interest (2019 - 2025)

Historic Minority Interest for BridgeBio Pharma (BBIO) over the last 7 years, with Q3 2025 value amounting to $10.3 million.

  • BridgeBio Pharma's Minority Interest fell 520.9% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 520.9%. This contributed to the annual value of $10.2 million for FY2024, which is 972.96% down from last year.
  • Latest data reveals that BridgeBio Pharma reported Minority Interest of $10.3 million as of Q3 2025, which was down 520.9% from $9.9 million recorded in Q2 2025.
  • BridgeBio Pharma's Minority Interest's 5-year high stood at $12.4 million during Q3 2023, with a 5-year trough of $336000.0 in Q1 2022.
  • In the last 5 years, BridgeBio Pharma's Minority Interest had a median value of $10.4 million in 2022 and averaged $9.1 million.
  • In the last 5 years, BridgeBio Pharma's Minority Interest plummeted by 9294.31% in 2021 and then soared by 354761.9% in 2023.
  • Over the past 5 years, BridgeBio Pharma's Minority Interest (Quarter) stood at $3.4 million in 2021, then surged by 230.66% to $11.3 million in 2022, then dropped by 0.34% to $11.2 million in 2023, then fell by 9.73% to $10.2 million in 2024, then increased by 1.66% to $10.3 million in 2025.
  • Its Minority Interest was $10.3 million in Q3 2025, compared to $9.9 million in Q2 2025 and $10.0 million in Q1 2025.